October 27, 2016
3 min watch

VIDEO: MedImmune collaborates with UCSF for treatment of patients with rheumatic diseases

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

PHILADELPHIA — Bing Yao, PhD, Head of Respiratory, Inflammation and Autoimmunity at MedImmune, spoke with Healio Rheumatology about MedImmune’s collaboration with the University of California at San Francisco, techniques to quantify biomarkers and MedImmune’s role in treating rheumatologic patients.